Skip to content
OpenCapital
Get started

Kimberly-Clark KMB Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
ARGENTINA1%—
Türkiye1%—

Other financials

Income statement

See full
Revenue$4.2B+2.7%
Gross profit$1.5B+1.7%
Operating income$753.0M+19.3%
Net income$665.0M+17.3%
EPS (diluted)$2.00+17.6%

Balance sheet

See full
Cash & equivalents$542.0M-1.6%
Total debt$7.1B-2.2%
Total equity$1.8B+63.1%
Total assets$17.2B+5.4%

Cash flow

See full
Operating cash flow$745.0M+128%
CapEx$424.0M+108%
Free cash flow$321.0M+161%

Valuation

See full
Market cap$36.3B-15.8%
Enterprise value$42.85B-13.8%
P/E17.1×-0.6×
P/S2.2×-0.4×

Profitability

See full
Gross margin35.9%-1.0pp
Operating margin14.9%-0.9pp
Net margin12.8%-2.1pp
FCF margin11.1%-3.4pp

Returns & leverage

See full
Return on equity146.3%-83.5pp
Debt / equity3.9×-2.6×
Current ratio0.8×0.0×